Doxil/Caelyx BE Study

Clinical trial NCT05567601 · COMPLETED

Trial details

NCT number: NCT05567601
Sponsor: Baxter Healthcare Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer AIDS-related Kaposi Sarcoma Multiple Myeloma Metastatic Breast Cancer

Start date: 2023-12-16
Primary completion: 2024-06-21
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.